• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Normal hepatic vitamin-D metabolism in icteric primary biliary cirrhosis associated with pronounced vitamin-D deficiency symptoms.

作者信息

Danielsson A, Lorentzon R, Larsson S E

出版信息

Hepatogastroenterology. 1982 Feb;29(1):6-8.

PMID:7095738
Abstract

The intestinal absorption and hepatic metabolism of vitamin D were studied in a woman with icteric primary biliary cirrhosis (PBC) complicated by pronounced bone pain and muscle weakness due to vitamin-D deficiency. The patient had a markedly reduced intestinal absorption of vitamin D, while the 25-hydroxylation of this vitamin was found to be normal despite the presence of longstanding icterus. The malabsorption of fat-soluble compounds secondary to the cholestasis was probably further impaired by several years of cholestyramine treatment. Administration of 1.25-(OH)2D3 increased intestinal calcium absorption, normalized serum calcium and increased bone mineral content of the proximal tibia. Furthermore, drastic improvement of muscle weakness and relief of bone pain were observed. It is recommended that repeated measurements of serum 25-(OH)D should be carried out in patients with PBC, and especially in those treated with cholestyramine. In certain vitamin D deficient patients, studies using radio-labelled vitamin D may provide clinically valuable information as to the exact site of the underlying disturbances.

摘要

相似文献

1
Normal hepatic vitamin-D metabolism in icteric primary biliary cirrhosis associated with pronounced vitamin-D deficiency symptoms.
Hepatogastroenterology. 1982 Feb;29(1):6-8.
2
Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.25-羟维生素D3对原发性胆汁性肝硬化患者维生素D代谢产物的影响
Gastroenterology. 1981 Oct;81(4):681-5.
3
Osteomalacia associated with cholestyramine therapy for postileectomy diarrhea.考来烯胺治疗术后腹泻所致的骨软化症
Gastroenterology. 1972 Apr;62(4):642-6.
4
Vitamin D metabolism in biliary atresia: intestinal absorptions of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3.胆道闭锁中的维生素D代谢:25-羟基维生素D3和1,25-二羟基维生素D3的肠道吸收
J Pediatr Gastroenterol Nutr. 1988 May-Jun;7(3):341-6.
5
Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis.原发性胆汁性肝硬化中25-羟维生素D的肠道吸收与骨软化症
Lancet. 1977 Apr 2;1(8014):721-4. doi: 10.1016/s0140-6736(77)92167-5.
6
Bone disease in patients with primary biliary cirrhosis.原发性胆汁性肝硬化患者的骨病
Prog Liver Dis. 1990;9:537-54.
7
Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment.原发性胆汁性肝硬化中的肝性骨营养不良:药物治疗的效果
Am J Gastroenterol. 1994 Jan;89(1):47-50.
8
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
9
[Systemic diseases affecting the skeletal system].
Z Gastroenterol Verh. 1986 Apr;21:27-34.
10
A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.使用氯膦酸盐加钙和维生素D补充剂进行4年治疗,对原发性胆汁性肝硬化患者的骨量并无改善作用。
Dig Liver Dis. 2007 Jun;39(6):544-8. doi: 10.1016/j.dld.2007.02.005. Epub 2007 Apr 6.

引用本文的文献

1
Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges.自身免疫性胆汁淤积性肝病中的肌少症性骨病:病因、治疗及挑战。
World J Gastroenterol. 2022 Apr 14;28(14):1430-1443. doi: 10.3748/wjg.v28.i14.1430.